1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow David E Gerber: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Study of TVB-2640 in KRAS Non-Small Cell Lung Carcinomas TVB-2640 - KRAS Gene Mutation | Phase 2 | Active not recruiting | David E Gerber | 18 | 2019-09-11 | 2026-05-22 |
TVB-2640 (1)
United States (1)
David Gerber, MD (1)